Pellegrini Laura, Wetzel Andrea, Grannó Simone, Heaton George, Harvey Kirsten
Department of Pharmacology, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK.
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Convent Drive, Bethesda, MD, 20982-3707, USA.
Cell Mol Life Sci. 2017 Feb;74(3):409-434. doi: 10.1007/s00018-016-2351-6. Epub 2016 Sep 6.
Cytoskeletal homeostasis is essential for the development, survival and maintenance of an efficient nervous system. Microtubules are highly dynamic polymers important for neuronal growth, morphology, migration and polarity. In cooperation with several classes of binding proteins, microtubules regulate long-distance intracellular cargo trafficking along axons and dendrites. The importance of a delicate interplay between cytoskeletal components is reflected in several human neurodegenerative disorders linked to abnormal microtubule dynamics, including Parkinson's disease (PD). Mounting evidence now suggests PD pathogenesis might be underlined by early cytoskeletal dysfunction. Advances in genetics have identified PD-associated mutations and variants in genes encoding various proteins affecting microtubule function including the microtubule-associated protein tau. In this review, we highlight the role of microtubules, their major posttranslational modifications and microtubule associated proteins in neuronal function. We then present key evidence on the contribution of microtubule dysfunction to PD. Finally, we discuss how regulation of microtubule dynamics with microtubule-targeting agents and deacetylase inhibitors represents a promising strategy for innovative therapeutic development.
细胞骨架稳态对于高效神经系统的发育、存活和维持至关重要。微管是高度动态的聚合物,对神经元生长、形态、迁移和极性很重要。微管与几类结合蛋白协同作用,调节沿轴突和树突的长距离细胞内货物运输。细胞骨架成分之间微妙相互作用的重要性体现在与微管动力学异常相关的几种人类神经退行性疾病中,包括帕金森病(PD)。现在越来越多的证据表明,PD发病机制可能始于早期细胞骨架功能障碍。遗传学进展已在编码影响微管功能的各种蛋白质(包括微管相关蛋白tau)的基因中鉴定出与PD相关的突变和变体。在本综述中,我们强调了微管、其主要的翻译后修饰以及微管相关蛋白在神经元功能中的作用。然后,我们展示了微管功能障碍对PD影响的关键证据。最后,我们讨论了用微管靶向药物和脱乙酰酶抑制剂调节微管动力学如何代表了一种有前景的创新治疗开发策略。